• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过诱变分析人核糖核酸酶抑制剂与血管生成素及核糖核酸酶A的相互作用:C末端“热点”内外抑制剂残基的重要性

Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".

作者信息

Shapiro R, Ruiz-Gutierrez M, Chen C Z

机构信息

Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, Boston, MA 02115, USA.

出版信息

J Mol Biol. 2000 Sep 15;302(2):497-519. doi: 10.1006/jmbi.2000.4075.

DOI:10.1006/jmbi.2000.4075
PMID:10970748
Abstract

Ribonuclease inhibitor (RI) binds diverse mammalian RNases with extraordinary avidity. Here, we have investigated the structural basis for this tight binding and broad specificity by mutational analysis of the complexes of RI with angiogenin (Ang) and RNase A (K(D)=0.5 fM and 43 fM, respectively). Both crystal structures are known; the interfaces are large, and the ligands dock similarly, although few of the specific interactions formed are analogous. Our previous mutagenesis studies focused primarily on one contact region, containing RI 434-438 and the enzymatic active site. Many single-residue replacements produced extensive losses of binding energy (2.3-5.9 kcal/mol), suggesting that this region constitutes a "hot spot" in both cases. We have now explored the roles of most of the remaining RI residues that interact with Ang and/or RNase A. One major cluster in each complex lies in a Trp-rich area of RI, containing Trp261, Trp263, Trp318, and Trp375. Although the energy losses from individual replacements in this portion of the Ang complex were small-to-moderate (0-1.5 kcal/mol), the changes from multiple substitutions were much greater than additive, and the binding energy provided by this region is estimated to be approximately 6 kcal/mol (30 % of total). Effects of replacing combinations of hot spot components had also been found to be superadditive, and this negative cooperativity is now shown to extend to the neighboring contact residue RI Ser460. The overall contribution of the hot spot, taking superadditivity into account, is then approximately 14-15 kcal/mol. The hot spot and Trp-rich regions, although spatially well separated, are themselves functionally linked. No other parts of the RI-Ang interface appear to be energetically important. Binding of RNase A is more sensitive to substitutions throughout the interface, with free energy losses>/=1 kcal/mol produced by nearly all replacements examined, so that the sum of losses greatly exceeds the binding energy of the complex. This discrepancy can be explained, in part, by positive cooperativity, as evident from the subadditive effects observed when combinations of residues in either the hot spot or Trp-rich region are replaced. These findings suggest that the binding energy may be more widely distributed in the RNase A complex than in the Ang complex.

摘要

核糖核酸酶抑制剂(RI)能以极高的亲和力结合多种哺乳动物核糖核酸酶。在此,我们通过对RI与血管生成素(Ang)和核糖核酸酶A(K(D)分别为0.5 fM和43 fM)复合物的突变分析,研究了这种紧密结合和广泛特异性的结构基础。两种复合物的晶体结构均已知;尽管形成的特定相互作用很少相似,但界面较大,且配体的对接方式类似。我们之前的诱变研究主要集中在一个接触区域,该区域包含RI 434 - 438和酶活性位点。许多单残基替换导致结合能大幅损失(2.3 - 5.9千卡/摩尔),这表明该区域在两种情况下均构成一个“热点”。我们现在探究了与Ang和/或核糖核酸酶A相互作用的其余大多数RI残基的作用。每种复合物中的一个主要簇位于RI富含色氨酸的区域,包含Trp261、Trp263、Trp318和Trp375。尽管Ang复合物中该部分单个替换导致的能量损失较小至中等(0 - 1.5千卡/摩尔),但多个替换产生的变化远大于相加效应,该区域提供的结合能估计约为6千卡/摩尔(占总量的30%)。还发现替换热点成分组合的效应具有超加性,并且这种负协同性现在表明延伸至相邻的接触残基RI Ser460。考虑到超加性,热点的总体贡献约为14 - 15千卡/摩尔。热点和富含色氨酸的区域虽然在空间上相隔较远,但它们在功能上相互关联。RI - Ang界面的其他部分似乎在能量上并不重要。核糖核酸酶A的结合对整个界面的替换更敏感,几乎所有检测的替换都会产生≥1千卡/摩尔的自由能损失,因此损失总和大大超过复合物的结合能。这种差异部分可以通过正协同性来解释,这从热点或富含色氨酸区域的残基组合被替换时观察到的次加性效应中可以明显看出。这些发现表明,核糖核酸酶A复合物中的结合能可能比Ang复合物中的分布更广泛。

相似文献

1
Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".通过诱变分析人核糖核酸酶抑制剂与血管生成素及核糖核酸酶A的相互作用:C末端“热点”内外抑制剂残基的重要性
J Mol Biol. 2000 Sep 15;302(2):497-519. doi: 10.1006/jmbi.2000.4075.
2
Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.胎盘核糖核酸酶抑制剂与血管生成素及核糖核酸酶A相互作用界面处“热点”突变的超加性和次加性效应
Biochemistry. 1999 Jul 20;38(29):9273-85. doi: 10.1021/bi990762a.
3
Mutational analysis of the complex of human RNase inhibitor and human eosinophil-derived neurotoxin (RNase 2).人核糖核酸酶抑制剂与人嗜酸性粒细胞衍生神经毒素(核糖核酸酶2)复合物的突变分析。
Biochemistry. 2003 Feb 18;42(6):1451-9. doi: 10.1021/bi026852o.
4
Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A.位点特异性诱变揭示了核糖核酸酶抑制剂与血管生成素和核糖核酸酶A紧密结合的结构基础的差异。
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1761-6. doi: 10.1073/pnas.94.5.1761.
5
Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.胎盘核糖核酸酶抑制剂对人嗜酸性粒细胞衍生神经毒素(核糖核酸酶2)的分子识别
J Mol Biol. 2005 Apr 1;347(3):637-55. doi: 10.1016/j.jmb.2005.01.035.
6
Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein.核糖核酸酶A与核糖核酸酶抑制剂蛋白结合的荧光测定法。
Anal Biochem. 2002 Jul 1;306(1):100-7. doi: 10.1006/abio.2002.5678.
7
Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.人血管生成素小分子抑制剂的鉴定及其结合相互作用的计算对接表征
Biochemistry. 2003 Jun 10;42(22):6674-87. doi: 10.1021/bi034164e.
8
Selective abolition of pancreatic RNase binding to its inhibitor protein.胰腺核糖核酸酶与其抑制蛋白结合的选择性消除。
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):53-8. doi: 10.1073/pnas.0307268101. Epub 2003 Dec 17.
9
Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.迈向核糖核酸酶抑制剂的合理设计:核糖核酸酶A与一种强效3',5'-焦磷酸连接二核苷酸抑制剂复合物的高分辨率晶体结构
Biochemistry. 1999 Aug 10;38(32):10287-97. doi: 10.1021/bi990900w.
10
Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.基于核糖核酸酶抑制剂蛋白与核糖核酸酶A复合物的晶体结构研究核糖核酸酶抑制剂抑制核糖核酸酶的机制。
J Mol Biol. 1996 Dec 20;264(5):1028-43. doi: 10.1006/jmbi.1996.0694.

引用本文的文献

1
Assessment of software methods for estimating protein-protein relative binding affinities.评估用于估算蛋白质-蛋白质相对结合亲和力的软件方法。
PLoS One. 2020 Dec 21;15(12):e0240573. doi: 10.1371/journal.pone.0240573. eCollection 2020.
2
Immune Modulation by Human Secreted RNases at the Extracellular Space.人分泌型核糖核酸酶在细胞外空间的免疫调节作用。
Front Immunol. 2018 May 16;9:1012. doi: 10.3389/fimmu.2018.01012. eCollection 2018.
3
Functional evolution of ribonuclease inhibitor: insights from birds and reptiles.核糖核酸酶抑制剂的功能进化:来自鸟类和爬行动物的启示。
J Mol Biol. 2014 Aug 26;426(17):3041-56. doi: 10.1016/j.jmb.2014.06.007. Epub 2014 Jun 15.
4
Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway.血管生成素通过ERK1/2途径调节基质金属蛋白酶-2的表达,从而促进肿瘤生长和血管生成。
Oncogene. 2015 Feb 12;34(7):890-901. doi: 10.1038/onc.2014.2. Epub 2014 Feb 24.
5
Crystal structures of murine angiogenin-2 and -3-probing 'structure--function' relationships amongst angiogenin homologues.鼠血管生成素-2 和 -3 的晶体结构揭示了血管生成素同源物之间的“结构-功能”关系。
FEBS J. 2013 Jan;280(1):302-18. doi: 10.1111/febs.12071. Epub 2012 Dec 11.
6
Specificity and cooperativity at β-lactamase position 104 in TEM-1/BLIP and SHV-1/BLIP interactions.β-内酰胺酶位置 104 处的特异性和协同性TEM-1/BLIP 和 SHV-1/BLIP 相互作用。
Proteins. 2011 Apr;79(4):1267-76. doi: 10.1002/prot.22961. Epub 2011 Feb 3.
7
Rate theories for biologists.生物学家的率论。
Q Rev Biophys. 2010 May;43(2):219-93. doi: 10.1017/S0033583510000120. Epub 2010 Aug 9.
8
Fundamental aspects of protein-protein association kinetics.蛋白质-蛋白质结合动力学的基本方面。
Chem Rev. 2009 Mar 11;109(3):839-60. doi: 10.1021/cr800373w.
9
Volume-based solvation models out-perform area-based models in combined studies of wild-type and mutated protein-protein interfaces.在野生型和突变型蛋白质-蛋白质界面的联合研究中,基于体积的溶剂化模型比基于面积的模型表现更优。
BMC Bioinformatics. 2008 Oct 21;9:448. doi: 10.1186/1471-2105-9-448.
10
Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.逃避核糖核酸酶抑制剂作为核糖核酸酶细胞毒性的一个决定因素。
Curr Pharm Biotechnol. 2008 Jun;9(3):185-9. doi: 10.2174/138920108784567344.